NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-56 Cr | ₹44 Cr | ₹42 Cr | ₹40 Cr | ₹2.59 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NEULAND LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-56 Cr |
| Mar2025 | ₹44 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹2.59 Cr |
How is Net Cash Inflow / Outflow of NEULAND LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-56 Cr | Negative | |
| Mar2025 | ₹44 Cr | 4.74 | |
| Mar2024 | ₹42 Cr | 5.74 | |
| Mar2023 | ₹40 Cr | 1,438.86 | |
| Mar2022 | ₹2.59 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹26,013.6 Cr | 3.6% | -2.7% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.6% |
-2.7% |
12.9% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses